2019•药物不良反应杂志Requires access

Delayed exfoliative dermatitis induced by piperacillin sodium and sulbactam sodium in a patient with negative skin test

Zhihui Sun, Hongmei Zhang, Jiqiu Hou, Yanhua Li

Open publisher page 0 citations

Abstract

A 59-year-old female patient received liver-protective drugs such as compound glycyrrhizin for liver cirrhosis and anti-infective agent piperacillin sodium and sulbactam sodium (2.5 g by an IV infusion, twice daily) for pneumonia, with the precondition of negative skin test. On day 4, the patient developed scattered small maculopapular rashes on her face, which then increased all over the body, located mainly in the trunk, and appeared as red round and irregular shapes, accompanied by local swelling of the mouth, and chapped lips. Considering that it was caused by piperacillin sodium and sulbactam sodium, the drug was discontinued and symptomatic and supportive treatments with methylprednisolone, desloratadine cirate disodium, and appropriate topical drugs were given immediately. Liver-protective drugs were continued and moxifloxacin was given for infection. On day 2 of drug withdrawal, the patient developed nasal and scattered skin desquamation on the nose and neck. Exfoliative dermatitis was diagnosed. On day 8 of admission, the erythema on the whole body became lighter, no new skin rashes appeared, and methylprednisolone was stopped. On day 13, the patient′s original rashes became lighter, crusted, and partially subsided. Key words: Hypersensitivity, delayed; Dermatitis, exfoliative; Piperacillin; Sulbactam; Skin tests

About this research paper

What this paper is about

A 59-year-old female patient received liver-protective drugs such as compound glycyrrhizin for liver cirrhosis and anti-infective agent piperacillin sodium and sulbactam sodium (2.5 g by an IV infusion, twice daily) for pneumonia, with the precondition of negative skin test. On day 4, the patient developed scattered small maculopapular rashes on her face, which then increased all over the body, located mainly in the trunk, and appeared as red round and irregular shapes, accompanied by local swelling of the mouth, and chapped lips. Considering that it was caused by piperacillin sodium and sulbactam sodium, the drug was discontinued and symptomatic and supportive treatments with methylprednisolone, desloratadine cirate disodium, and appropriate topical drugs were given immediately. Liver-protective drugs were continued and moxifloxacin was given for infection. On day 2 of drug withdrawal, the patient developed nasal and scattered skin desquamation on the nose and neck. Exfoliative dermatitis was diagnosed. On day 8 of admission, the erythema on the whole body became lighter, no new skin rashes appeared, and methylprednisolone was stopped. On day 13, the patient′s original rashes became lighter, crusted, and partially subsided. Key words: Hypersensitivity, delayed; Dermatitis, exfoliative; Piperacillin; Sulbactam; Skin tests

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A 59-year-old female patient received liver-protective drugs such as compound glycyrrhizin for liver cirrhosis and anti-infective agent piperacillin sodium and sulbactam sodium (2.5 g by an IV infusion, twice daily) for pneumonia, with the precondition of negative skin test. On day 4, the patient developed scattered small maculopapular rashes on her face, which then increased all over the body, located mainly in the trunk, and appeared as red round and irregular shapes, accompanied by local swelling of the mouth, and chapped lips. Considering that it was caused by piperacillin sodium and sulbactam sodium, the drug was discontinued and symptomatic and supportive treatments with methylprednisolone, desloratadine cirate disodium, and appropriate topical drugs were given immediately. Liver-protective drugs were continued and moxifloxacin was given for infection. On day 2 of drug withdrawal, the patient developed nasal and scattered skin desquamation on the nose and neck. Exfoliative dermatitis was diagnosed. On day 8 of admission, the erythema on the whole body became lighter, no new skin rashes appeared, and methylprednisolone was stopped. On day 13, the patient′s original rashes became lighter, crusted, and partially subsided. Key words: Hypersensitivity, delayed; Dermatitis, exfoliative; Piperacillin; Sulbactam; Skin tests

Key concepts: Medicine, Dermatology, Erythema, Nose, Sulbactam, Exfoliative dermatitis, Anesthesia, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
Delayed exfoliative dermatitis induced by piperacillin sodium and sulbactam sodium in a patient with negative skin test — Research Paper | ScholarLens